("World High Life" or the "Company")
LOVE HEMP APPOINTS NEW SCIENTIFIC ADVISORS TO ITS ADVISORY BOARD
World High Life Grants Options to Consultants and Directors
The scientific advisory board appointments bolster Love Hemp's focus on the continued development of proprietary, industry leading formulations to address specific health and wellness needs.
Scientific Advisory Board Announcement Highlights:
· Dr.
·
· Dr.
·
· Together,
Dr.
Dr.
Dr.
Grant of Options
World High Life announces that the Board has granted options ("Share Options") over an aggregate of 3,300,000 ordinary shares of 1p each in the Company ("Ordinary Shares") to certain directors and consultants of Love Hemp, including options over 950,000 Ordinary Shares to each of
The Share Options all have an exercise price of 12.8p per share and may be exercised at any time six months after the date of grant and not later than the fifth anniversary of the date of grant, subject to continued employment.
For further information please contact:
Founder & CEO +44 (0) 7926 397 675 |
|
|
|
AQSE Corporate Adviser +44 (0) 20 7469 0930 |
Financial PR Blytheweigh +44 (0) 20 7138 3224 Camilla.horsfall@blytheweigh.com
|
For more information on World High Life please visit: www.worldhighlife.uk
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
||
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
|
|
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b)
|
Initial notification /Amendment |
Initial |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
|
|
b) |
LEI |
213800ERYVHIGFSPMM75 |
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 1p each
GB00BK26FQ62 |
b) |
Nature of the transaction |
Grant of Options |
c) |
Price(s) and volume(s) |
Grant of options over 950,000 ordinary shares with an exercise price of 12.8p per share |
d) |
Aggregated information - Aggregated volume - Price |
N/A
|
e) |
Date of the transaction |
|
f) |
Place of the transaction |
AQSE Growth Market (AQSE) |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
||
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
a) |
|
|
2 |
Reason for the notification |
|
a) |
Position/status |
PDMR |
b)
|
Initial notification /Amendment |
Initial |
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
|
|
b) |
LEI |
213800ERYVHIGFSPMM75 |
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of 1p each
GB00BK26FQ62 |
b) |
Nature of the transaction |
Grant of Options |
c) |
Price(s) and volume(s) |
Grant of options over 950,000 ordinary shares with an exercise price of 12.8p per share |
d) |
Aggregated information - Aggregated volume - Price |
N/A
|
e) |
Date of the transaction |
|
f) |
Place of the transaction |
AQSE Growth Market (AQSE) |
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a
Cautionary Note Regarding Forward Looking Information
We seek safe harbour. Some statements contained in this news release are "forward looking information" within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", "believes" or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management's current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.
This information is provided by RNS, the news service of the